212 related articles for article (PubMed ID: 16288053)
41. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
[TBL] [Abstract][Full Text] [Related]
42. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.
Cui Y; Niu A; Pestell R; Kumar R; Curran EM; Liu Y; Fuqua SA
Mol Endocrinol; 2006 Sep; 20(9):2020-35. PubMed ID: 16645043
[TBL] [Abstract][Full Text] [Related]
43. Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1.
Hahm K; Sum EY; Fujiwara Y; Lindeman GJ; Visvader JE; Orkin SH
Mol Cell Biol; 2004 Mar; 24(5):2074-82. PubMed ID: 14966286
[TBL] [Abstract][Full Text] [Related]
44. LIM only 4 is overexpressed in late stage pancreas cancer.
Yu J; Ohuchida K; Nakata K; Mizumoto K; Cui L; Fujita H; Yamaguchi H; Egami T; Kitada H; Tanaka M
Mol Cancer; 2008 Dec; 7():93. PubMed ID: 19099607
[TBL] [Abstract][Full Text] [Related]
45. Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR.
Palijan A; Fernandes I; Bastien Y; Tang L; Verway M; Kourelis M; Tavera-Mendoza LE; Li Z; Bourdeau V; Mader S; Yang XJ; White JH
J Biol Chem; 2009 Oct; 284(44):30264-74. PubMed ID: 19744931
[TBL] [Abstract][Full Text] [Related]
46. SPEN, a new player in primary cilia formation and cell migration in breast cancer.
Légaré S; Chabot C; Basik M
Breast Cancer Res; 2017 Sep; 19(1):104. PubMed ID: 28877752
[TBL] [Abstract][Full Text] [Related]
47. LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP.
Bennesch MA; Segala G; Wider D; Picard D
Nucleic Acids Res; 2016 Oct; 44(18):8655-8670. PubMed ID: 27325688
[TBL] [Abstract][Full Text] [Related]
48. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
[TBL] [Abstract][Full Text] [Related]
49. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
50. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
51. Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells.
Park E; Gong EY; Romanelli MG; Lee K
Biochem Biophys Res Commun; 2012 May; 421(3):532-7. PubMed ID: 22521644
[TBL] [Abstract][Full Text] [Related]
52. Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivation.
Talukder AH; Li DQ; Manavathi B; Kumar R
Oncogene; 2008 Sep; 27(39):5233-42. PubMed ID: 18521086
[TBL] [Abstract][Full Text] [Related]
53. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
[TBL] [Abstract][Full Text] [Related]
54. The LIM-only protein LMO4 modulates the transcriptional activity of HEN1.
Manetopoulos C; Hansson A; Karlsson J; Jönsson JI; Axelson H
Biochem Biophys Res Commun; 2003 Aug; 307(4):891-9. PubMed ID: 12878195
[TBL] [Abstract][Full Text] [Related]
55. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation.
Loven MA; Muster N; Yates JR; Nardulli AM
Mol Endocrinol; 2003 Jan; 17(1):67-78. PubMed ID: 12511607
[TBL] [Abstract][Full Text] [Related]
56. Altered target gene regulation controlled by estrogen receptor-alpha concentration.
Fowler AM; Solodin NM; Valley CC; Alarid ET
Mol Endocrinol; 2006 Feb; 20(2):291-301. PubMed ID: 16179380
[TBL] [Abstract][Full Text] [Related]
57. Loss of the LIM domain protein Lmo4 in the mammary gland during pregnancy impedes lobuloalveolar development.
Sum EY; Shackleton M; Hahm K; Thomas RM; O'Reilly LA; Wagner KU; Lindeman GJ; Visvader JE
Oncogene; 2005 Jul; 24(30):4820-8. PubMed ID: 15856027
[TBL] [Abstract][Full Text] [Related]
58. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
[TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
Wihlén B; Ahmed S; Inzunza J; Matthews J
Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
[TBL] [Abstract][Full Text] [Related]
60. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
